Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma
about
Three-drug versus two-drug induction therapy regimens for patients with transplant-eligible multiple myelomaThe myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteinsTreatment of multiple myeloma bone disease: experimental and clinical data.Novel insights into the mechanism of action of lenalidomide.Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.Expanding role of lenalidomide in hematologic malignanciesLenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease.Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.Can lenalidomide play a role in the management of scleritis?Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophyCellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses.Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma.Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.Treatment options for mantle cell lymphoma.Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.Trial Watch: Lenalidomide-based immunochemotherapy.Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Aus
P2860
Q24202358-0DD20B0D-1953-45A3-8549-4389C94DFCD2Q28303081-11FDF9ED-7AD4-4567-AD2A-C3A83CA23262Q30868833-68738E28-B617-431E-B451-6F0AEF708DF2Q34373253-68FE4077-54F3-4068-B74B-F45168B97A45Q35171777-AA6FDAFC-2F86-4CC4-A5D1-7520106824E3Q35592305-A1C2AB64-0ABD-4317-9E49-EC79CF18A11FQ35609611-F1495F7D-4B28-494B-8A02-0F6F21F201A9Q35688891-97BC5CDE-1482-4DF1-8529-41A448ACE00CQ36986670-28C42582-BD5E-470D-B8FF-F5F98D429EF4Q37565960-BDCB90FE-151C-4B04-AECF-C69D3224794DQ38150127-E6F62BD5-126B-4852-B791-6008052967E8Q38206386-6EDF85D8-086E-443B-BD6B-5BC282635BF1Q38311896-F6145600-6A9A-44D9-A890-2A6C2B5824C3Q38413040-A86ADB81-756D-4C13-9D0E-DE6DA8CF4150Q38584922-9DA9FDD2-0E34-400A-B9AC-558AAFE718C2Q38795045-9F1CC5F3-D74E-4DC1-BAE1-0D477FD0D926Q40527891-7DD283EE-1BDB-4F0D-850C-F4ECD7D838F7Q42737828-FF27A765-B4DC-4000-B95A-259F24603EE1Q44449693-C7323E96-E94F-4D8E-88AE-B4A7D6DDF27DQ53797232-CE7E2EF1-B58D-4535-B7F1-F17B1D9437EC
P2860
Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Biological activity of lenalid ...... ic effects in multiple myeloma
@ast
Biological activity of lenalid ...... ic effects in multiple myeloma
@en
Biological activity of lenalid ...... ic effects in multiple myeloma
@en-gb
Biological activity of lenalid ...... ic effects in multiple myeloma
@nl
type
label
Biological activity of lenalid ...... ic effects in multiple myeloma
@ast
Biological activity of lenalid ...... ic effects in multiple myeloma
@en
Biological activity of lenalid ...... ic effects in multiple myeloma
@en-gb
Biological activity of lenalid ...... ic effects in multiple myeloma
@nl
altLabel
Biological Activity of Lenalid ...... ic Effects in Multiple Myeloma
@en
prefLabel
Biological activity of lenalid ...... ic effects in multiple myeloma
@ast
Biological activity of lenalid ...... ic effects in multiple myeloma
@en
Biological activity of lenalid ...... ic effects in multiple myeloma
@en-gb
Biological activity of lenalid ...... ic effects in multiple myeloma
@nl
P2093
P2860
P356
P1476
Biological activity of lenalid ...... ic effects in multiple myeloma
@en
P2093
Alessandra Lombardo
Anna Marina Liberati
Chiara Di Sano
Roberta Martiniani
Valentina Di Loreto
P2860
P304
P356
10.1155/2012/842945
P407
P577
2012-01-01T00:00:00Z